by nms-sync | Sep 21, 2023 | News
Nerviano Medical Sciences (NMS), una Biotech focalizzata sulla ricerca e sviluppo di farmaci Oncologici innovativi, partecipa alla Settimana Europea delle Biotecnologie (European Biotech Week – EBW), giunta quest’anno alla sua XI edizione.
...
by nms-sync | Sep 20, 2023 | News
Nerviano, September 20, 2023 – Nerviano Medical Sciences S.r.l. (NMS), a member of NMS Group S.p.A. and a clinical stage biotech, discovering and developing innovative therapies for the treatment of cancer, today announces the publication of preclinical data on...
by nms-sync | Sep 19, 2023 | News
September 19th, 2023
2023 | News
NERVIANO, Italy—September 19th, 2023—SIMIS Srl (SIMIS), a NMS Group company, is pleased to announce the appointment of Laurent Contaut as the new Chief Executive Officer (CEO) of the organization, effective...
by nms-sync | Sep 11, 2023 | News
Nerviano Italy, 11 September 2023 – Nerviano Medical Sciences Srl (NMS Srl), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that Alberto Ocana PhD, has joined the Global...
by nms-sync | Aug 1, 2023 | News
NERVIANO, IT and BOSTON, Mass., August 1, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and the largest oncological R&D company in Italy, announced today the...
by nms-sync | Jun 22, 2023 | News
Nerviano 22 June 2023_Nerviano Medical Sciences Srl (NMS), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, is delighted to announce the FDA Clearance of Investigational New Drug (IND)...
Welcome and Check out our new motion picture!
Recent Comments